CCS Cell Culture Service GmbH Acquires the MaxCyte, Inc. STX(TM) Scalable Transfection System for Cell Line Development
GAITHERSBURG, Md. & HAMBURG, Germany--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance cell loading systems, is pleased to announce that CCS Cell Culture Service GmbH has acquired the MaxCyte® STX™ Scalable Transfection System to develop and optimize cells for the pharmaceutical industry.